logo

AIFF

Firefly Neuroscience·NASDAQ
--
--(--)
--
--(--)
9.66 / 10
Outperform

The company boasts outstanding fundamentals (9.7/10), highlighted by a strong asset-liability ratio of 22.16% (group 3) and an impressive interest-coverage ratio of 15.48 (group 2). However, metrics like Asset-MV (-0.50) and Revenue-MV (-2.99) fall into the least favorable quartiles, indicating potential valuation risks and slower revenue growth relative to market value.

Fundamental(9.66)SentimentTechnical

Analysis Checks(3/10)

Revenue-MV
Value-3.00
Score1/3
Weight-17.86%
1M Return-1.14%
Asset-liability ratio (%)
Value22.16
Score2/3
Weight35.92%
1M Return2.03%
Annualized return on equity (%)
Value-626.65
Score0/3
Weight-26.36%
1M Return-1.72%
Operating cycle
Value40.45
Score3/3
Weight115.26%
1M Return6.52%
Profit-MV
Value0.46
Score1/3
Weight29.24%
1M Return1.71%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score3/3
Weight53.20%
1M Return2.95%
Asset-MV
Value-0.50
Score0/3
Weight-71.19%
1M Return-5.22%
ROE (%)
Value-469.98
Score0/3
Weight-26.36%
1M Return-1.72%
Inventory turnover days
Value40.45
Score1/3
Weight22.63%
1M Return1.30%
Cash-MV
Value-0.07
Score0/3
Weight-14.48%
1M Return-0.93%
Is AIFF fundamentally strong?
  • AIFF scores 9.66/10 on fundamentals and holds a Discounted valuation at present. Backed by its -469.98% ROE, -2705.87% net margin, -0.38 P/E ratio, 1.09 P/B ratio, and -53.74% earnings growth, these metrics solidify its Outperform investment rating.